Εμφάνιση απλής εγγραφής

dc.creatorPetinaki, E.en
dc.creatorKontos, F.en
dc.creatorPratti, A.en
dc.creatorSkulakis, C.en
dc.creatorManiatis, A. N.en
dc.date.accessioned2015-11-23T10:45:25Z
dc.date.available2015-11-23T10:45:25Z
dc.date.issued2003
dc.identifier10.1016/s0924-8579(02)00253-4
dc.identifier.issn0924-8579
dc.identifier.urihttp://hdl.handle.net/11615/32181
dc.description.abstractA total of 300 Streptococcus pyogenes isolates, collected during 2001 from five hospitals in the Thessalia district (Central Greece), were examined for their resistance to macrolides. Resistance to erythromycin was detected in 58 isolates (19.3%). Of these, 68.9% were susceptible to clindamycin (M-phenotype) and carried the mefA gene. Of the remaining isolates, 18 expressed the MLSB phenotype: 12 and six exhibited inducible and constitutive resistance to clindamycin, respectively. All of these strains were found to be ermA (TR) positive, except for four that had the ermB gene. Of the erythromycin-resistant strains, none was found to be resistant to penicillin, tetracycline or quinupristin-dalfopristin. Molecular typing by PFGE showed the presence of a limited number of clones. (C) 2002 Elsevier Science B.V. and International Society of Chemotherapy. All rights reserved.en
dc.sourceInternational Journal of Antimicrobial Agentsen
dc.source.uri<Go to ISI>://WOS:000180905200010
dc.subjectmacrolide-resistanceen
dc.subjectStreptococcus pyogenesen
dc.subjectGROUP-A STREPTOCOCCUSen
dc.subjectERYTHROMYCIN RESISTANCEen
dc.subjectPREVALENCEen
dc.subjectDETERMINANTSen
dc.subjectCHILDRENen
dc.subjectCANADAen
dc.subjectInfectious Diseasesen
dc.subjectMicrobiologyen
dc.subjectPharmacology & Pharmacyen
dc.titleClinical isolates of macrolide-resistant Streptococcus pyogenes in Central Greeceen
dc.typejournalArticleen


Αρχεία σε αυτό το τεκμήριο

ΑρχείαΜέγεθοςΤύποςΠροβολή

Δεν υπάρχουν αρχεία που να σχετίζονται με αυτό το τεκμήριο.

Αυτό το τεκμήριο εμφανίζεται στις ακόλουθες συλλογές

Εμφάνιση απλής εγγραφής